Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Swanton

Showing results (11-20 of 439) with videos related to

Pageof 44
Sort By:
Clinical Chemistry|November 2, 2012
Plasma-derived tumor DNA analysis at whole-genome resolutionCharles Swanton
Cancer Research|September 25, 2012
Intratumor heterogeneity: evolution through space and timeCharles Swanton
Cancer Cell|January 14, 2015
Biological and therapeutic impact of intratumor heterogeneity in cancer evolutionNicholas McGranahan, Charles Swanton
Cancer Research|February 15, 2023
Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder CancerDeborah Caswell, Charles Swanton
BMJ (Clinical Research Ed.)|May 31, 2020
Protecting "covid protected" cancer hubsCharles Swanton, Henry Scowcroft
Annals of the New York Academy of Sciences|October 27, 2010
From genomic landscapes to personalized cancer management-is there a roadmap?Charles Swanton, Carlos Caldas
Idrugs : the Investigational Drugs Journal|April 2, 2004
New Targets and Innovative Strategies in Cancer Treatment: one year of progress. 13-14 February 2004, Nice, FranceCharles Swanton, Stephen Johnston
Cell Cycle (Georgetown, Tex.)|October 31, 2015
Tetraploidy and CIN: a dangerous combinationSally Dewhurst, Charles Swanton
Nature Reviews. Drug Discovery|April 29, 2017
Implications of cancer evolution for drug developmentSamra Turajlic, Charles Swanton
Nature Reviews. Clinical Oncology|August 23, 2017
Evolution and cancer medicine - transformative insightsErik Sahai, Charles Swanton,
Pageof 44

Showing results (11-20 of 439) with videos related to

Sort By:
Pageof 44
Clinical Chemistry|November 2, 2012
Plasma-derived tumor DNA analysis at whole-genome resolutionCharles Swanton
Cancer Research|September 25, 2012
Intratumor heterogeneity: evolution through space and timeCharles Swanton
Cancer Cell|January 14, 2015
Biological and therapeutic impact of intratumor heterogeneity in cancer evolutionNicholas McGranahan, Charles Swanton
Cancer Research|February 15, 2023
Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder CancerDeborah Caswell, Charles Swanton
BMJ (Clinical Research Ed.)|May 31, 2020
Protecting "covid protected" cancer hubsCharles Swanton, Henry Scowcroft
Annals of the New York Academy of Sciences|October 27, 2010
From genomic landscapes to personalized cancer management-is there a roadmap?Charles Swanton, Carlos Caldas
Idrugs : the Investigational Drugs Journal|April 2, 2004
New Targets and Innovative Strategies in Cancer Treatment: one year of progress. 13-14 February 2004, Nice, FranceCharles Swanton, Stephen Johnston
Cell Cycle (Georgetown, Tex.)|October 31, 2015
Tetraploidy and CIN: a dangerous combinationSally Dewhurst, Charles Swanton
Nature Reviews. Drug Discovery|April 29, 2017
Implications of cancer evolution for drug developmentSamra Turajlic, Charles Swanton
Nature Reviews. Clinical Oncology|August 23, 2017
Evolution and cancer medicine - transformative insightsErik Sahai, Charles Swanton,
Pageof 44